EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Creative Medical Technology Holdings's Enterprise Value is $-3.43 Mil.
Creative Medical Technology Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-8.03 Mil. Therefore, Creative Medical Technology Holdings's EV-to-FCF for today is 0.43.
The historical rank and industry rank for Creative Medical Technology Holdings's EV-to-FCF or its related term are showing as below:
CELZ'
s EV-to-FCF Range Over the Past 10 Years
Min: -122.24 Med: -1.8 Max: 3.67
Current: 0.43
During the past 13 years, the highest EV-to-FCF of Creative Medical Technology Holdings was 3.67. The lowest was -122.24. And the median was -1.80.
CELZ's EV-to-FCF is ranked better than 79.18% of 389
companies
in the Biotechnology industry
Industry Median: 4.27
vs CELZ: 0.43
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-23), Creative Medical Technology Holdings's stock price is $4.8201.
Creative Medical Technology Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-3.710. Therefore, Creative Medical Technology Holdings's PE Ratio for today is At Loss.
Creative Medical Technology Holdings EV-to-FCF Historical Data
The historical data trend for Creative Medical Technology Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Creative Medical Technology Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creative Medical Technology Holdings EV-to-FCF Distribution
For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Creative Medical Technology Holdings's EV-to-FCF falls into.
Creative Medical Technology Holdings EV-to-FCF Calculation
Creative Medical Technology Holdings's EV-to-FCF for today is calculated as:
Creative Medical Technology Holdings's current Enterprise Value is $-3.43 Mil.
Creative Medical Technology Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creative Medical Technology Holdings (NAS:CELZ) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Creative Medical Technology Holdings's PE Ratio for today is calculated as:
Creative Medical Technology Holdings's share price for today is $4.8201.
Creative Medical Technology Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.710.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Creative Medical Technology Holdings EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Creative Medical Technology Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Creative Medical Technology Holdings (Creative Medical Technology Holdings) Business Description
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CELZ has been successfully added to your 